Currently, there are 11.63M common shares owned by the public and among those 10.16M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 0.7122, up 6.37%. The company’s stock has a 5-day price change of 11.67% and 1.52% over the past three months. CMMB shares are trading 31.37% year to date (YTD), with the 12-month market performance down to -65.99% lower. It has a 12-month low price of $0.42 and touched a high of $2.70 over the same period. CMMB has an average intraday trading volume of 146.67K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 17.38%, 24.73%, and -32.54% respectively.
Institutional ownership of Chemomab Therapeutics Ltd ADR (NASDAQ: CMMB) shares accounts for 4.45% of the company’s 11.63M shares outstanding.
It has a market capitalization of $8.31M and a beta (3y monthly) value of 0.30. The earnings-per-share (ttm) stands at -$2.55. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.86% over the week and 7.36% over the month.
Analysts forecast that Chemomab Therapeutics Ltd ADR (CMMB) will achieve an EPS of $Cambium Networks Corporation for the current quarter, $4.21 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Climb Global Solutions, Inc. while analysts give the company a high EPS estimate of $FIRST COMM BANCORP INC. Comparatively, EPS for the current quarter was $GMMB a year ago. Earnings per share for the fiscal year are expected to increase by 4.17%, and 39.13% over the next financial year.
Looking at the support for the CMMB, a number of firms have released research notes about the stock. ROTH MKM stated their Buy rating for the stock in a research note on December 19, 2023, with the firm’s price target at $7.
